New business plans for direct-to-consumer gene testing industry

| December 14, 2012
money genes
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The Direct-to-Consumer (DTC) gene testing industry has generated a lot of press over the last five or six years. But the business plan has always seemed rather on the South Park side of logical. Now two of the major players in the gene testing industry — 23andMe and Family Tree DNA — along with upstart GenePeeks are launching new ventures that could remake the direct-to-consumer (DTC) market.

Additional Resources:

 View the original article here: New Business Plans for the Direct-to-Consumer Gene Testing Industry?

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend